Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ho

Showing results (1111-1120 of 1,367) with videos related to

Pageof 137
Sort By:
Annals of Hematology|May 15, 2014
Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA studyMathias Witzens-Harig, Robin Foá, Alice Di Rocco, et al.
Laryngoscope Investigative Otolaryngology|December 22, 2022
The next step: Replacing step 1 as a metric for residency applicationGarrett A Berk, Tiffany D Ho, Taylor J Stack-Pyle, et al.
British Journal of Haematology|October 10, 2015
Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trialMathias Witzens-Harig, Axel Benner, Fabienne McClanahan, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitorS M Poppe, D E Slade, K T Chong, et al.
Iscience|March 17, 2023
Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boostManoj S Nair, Ruy M Ribeiro, Maple Wang, et al.
Haematologica|February 10, 2022
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and <i>BCR-ABL</i>-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicinSabine Kayser, Chiara Sartor, Marlise R Luskin, et al.
Blood|February 12, 2011
Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14)Tilmann Bochtler, Ute Hegenbart, Christiane Heiss, et al.
Blood Cancer Journal|July 30, 2016
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemiaS Kayser, A Benner, C Thiede, et al.
Journal of Medical Virology|March 11, 2024
Low antibody levels associated with significantly increased rate of SARS-CoV-2 infection in a highly vaccinated population from the US National Basketball AssociationCaroline G Tai, Miriam J Haviland, Steven M Kissler, et al.
Blood|June 29, 2010
Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assayArnt V Kristen, Evangelos Giannitsis, Stephanie Lehrke, et al.
Pageof 137

Showing results (1111-1120 of 1,367) with videos related to

Sort By:
Pageof 137
Annals of Hematology|May 15, 2014
Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA studyMathias Witzens-Harig, Robin Foá, Alice Di Rocco, et al.
Laryngoscope Investigative Otolaryngology|December 22, 2022
The next step: Replacing step 1 as a metric for residency applicationGarrett A Berk, Tiffany D Ho, Taylor J Stack-Pyle, et al.
British Journal of Haematology|October 10, 2015
Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trialMathias Witzens-Harig, Axel Benner, Fabienne McClanahan, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitorS M Poppe, D E Slade, K T Chong, et al.
Iscience|March 17, 2023
Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boostManoj S Nair, Ruy M Ribeiro, Maple Wang, et al.
Haematologica|February 10, 2022
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and <i>BCR-ABL</i>-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicinSabine Kayser, Chiara Sartor, Marlise R Luskin, et al.
Blood|February 12, 2011
Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14)Tilmann Bochtler, Ute Hegenbart, Christiane Heiss, et al.
Blood Cancer Journal|July 30, 2016
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemiaS Kayser, A Benner, C Thiede, et al.
Journal of Medical Virology|March 11, 2024
Low antibody levels associated with significantly increased rate of SARS-CoV-2 infection in a highly vaccinated population from the US National Basketball AssociationCaroline G Tai, Miriam J Haviland, Steven M Kissler, et al.
Blood|June 29, 2010
Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assayArnt V Kristen, Evangelos Giannitsis, Stephanie Lehrke, et al.
Pageof 137